• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Ciclopirox
Date Designated: 04/17/2018
Orphan Designation: Treatment of congenital erythropoietic porphyria
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Atlas Molecular Pharma S.L.
Parque Tecnológico de Bizkaia
Building 800
Derio
Spain

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-